We are live on ! Find out more
HAE icon

Haemonetics
HAE

195 hedge funds and large institutions have $2.18B invested in Haemonetics in 2013 Q2 according to their latest regulatory filings, with 195 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

102.87% more ownership

Funds ownership: 0% → 102.87% (+103%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $248K

Holders
195
Holders Change
+195
Holders Change %
–
% of All Funds
6.34%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
195
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$248K
Net Calls
-$248K
Net Calls Change
-$248K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

HAE Hedge Fund Activity: Q2 2013 in Review

195 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q2 2013, worth a combined $2.18B.

Buyers outnumbered sellers: 195 funds opened new HAE positions and 0 closed out — a net gain of 195 holders — while 0 added to existing stakes and 0 trimmed.

  • 195 institutional investors held Haemonetics (HAE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.18B of Haemonetics stock for Q2 2013.
  • 195 funds opened new Haemonetics positions in Q2 2013 and 0 closed out, a net change of +195 holders.

Based on aggregated 13F filings for Q2 2013.